Delilah Alvarado
Staff ReporterDelilah is a staff reporter for BioPharma Dive. Before Industry Dive she covered business tech and startup news and has reported on social issues, politics and culture. She has a B.S. from Texas State University and is obsessed with dogs and horror films.
272 articles by Delilah Alvarado
-
Biogen sees ‘encouraging’ trends for postpartum depression drug
April 24, 2024 -
Former Bristol Myers CEO tapped as Novartis’ next board chair
April 23, 2024 -
Lilly to buy injectable drug plant in manufacturing ramp-up
April 22, 2024 -
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
April 22, 2024 -
Regeneron commits $500M to new venture capital fund
April 15, 2024 -
Century buys a startup, raises funding in cell therapy expansion
April 11, 2024 -
J&J, Rallybio partner on drug development for rare fetal condition
April 10, 2024 -
New postpartum depression drugs are here. Diagnosis, treatment hurdles still stand in the way.
April 10, 2024 -
Pfizer, with new study results, seeks to bring RSV shot to adults aged 18-59
April 9, 2024 -
Boehringer Ingelheim to lay off staff amid biosimilar challenges
April 5, 2024 -
Roivant reveals positive immune drug data, share buyback plans
April 2, 2024 -
Vertex moves kidney disease drug into late-stage testing
April 1, 2024 -
Moderna gets Blackstone backing for flu vaccine R&D
March 27, 2024 -
Supreme Court weighs abortion opponents’ standing in mifepristone case
March 26, 2024 -
AbbVie to buy immune drug developer Landos
March 25, 2024 -
NextCure to lay off 37% of staff, dial back research plans
March 21, 2024 -
With new data, Bayer readies rival to Astellas menopause drug
March 19, 2024 -
Bluebird, short on cash, takes on $175M in debt financing
March 18, 2024 -
Merck reveals plans to develop newer HPV shots
March 13, 2024 -
Boehringer, Sosei Heptares team up in schizophrenia drug deal
March 11, 2024 -
Alumis, taking aim at Bristol Myers, pulls in $259M for TYK2 drug work
March 6, 2024 -
CVS, Walgreens to start selling abortion pill in some states
March 4, 2024 -
CDC panel mulls changes to RSV vaccine recommendation
March 1, 2024 -
Women’s health company Obseva to wind down, lay off staff
Feb. 28, 2024 -
Denali, fresh off study setback, gets $500M lift
Feb. 27, 2024